TY  - GEN
AU  - Myers,R M
AU  - Greiner,S M
AU  - Harvey,M E
AU  - Griesmann,G
AU  - Kuffel,M J
AU  - Buhrow,S A
AU  - Reid,J M
AU  - Federspiel,M
AU  - Ames,M M
AU  - Dingli,D
AU  - Schweikart,K
AU  - Welch,A
AU  - Dispenzieri,A
AU  - Peng,K-W
AU  - Russell,S J
TI  - Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide
SN  - 1532-6535
PY  - 2007///1206
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents, Alkylating
KW  - pharmacology
KW  - Cell Line, Tumor
KW  - Cyclophosphamide
KW  - Female
KW  - Humans
KW  - Injections, Intravenous
KW  - Measles virus
KW  - genetics
KW  - Membrane Cofactor Protein
KW  - Mice
KW  - Mice, Inbred ICR
KW  - Mice, SCID
KW  - Mice, Transgenic
KW  - Multiple Myeloma
KW  - drug therapy
KW  - Oncolytic Virotherapy
KW  - adverse effects
KW  - Oncolytic Viruses
KW  - RNA, Viral
KW  - isolation & purification
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Saimiri
KW  - Symporters
KW  - Transplantation, Heterologous
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.clpt.6100409
ER  -